TY - JOUR
T1 - Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now
AU - the International Head and Neck Scientific Group
AU - Tufano, Ralph P.
AU - Pace-Asciak, Pia
AU - Russell, Jonathon O.
AU - Suárez, Carlos
AU - Randolph, Gregory W.
AU - López, Fernando
AU - Shaha, Ashok R.
AU - Mäkitie, Antti
AU - Rodrigo, Juan P.
AU - Kowalski, Luiz Paulo
AU - Zafereo, Mark
AU - Angelos, Peter
AU - Ferlito, Alfio
N1 - Publisher Copyright:
© Copyright © 2021 Tufano, Pace-Asciak, Russell, Suárez, Randolph, López, Shaha, Mäkitie, Rodrigo, Kowalski, Zafereo, Angelos and Ferlito.
PY - 2021/6/24
Y1 - 2021/6/24
N2 - Thermal and chemical ablation are minimally invasive procedures that avoid removal of the thyroid gland and target symptomatic nodules directly. Internationally, Radiofrequency ablation (RFA) is among one of the most widely used thermal ablative techniques, and is gaining traction in North America. Surgery remains the standard of care for most thyroid cancer, and in the right clinical setting, Active Surveillance (AS) can be a reasonable option for low risk disease. Minimally invasive techniques have emerged as an alternative option for patients deemed high risk for surgery, or for those patients who wish to receive a more active treatment approach compared to AS. Herein, we review the literature on the safety and efficacy of RFA for treating benign non-functioning thyroid nodules, autonomously functioning thyroid nodules, primary small low risk thyroid cancer (namely papillary thyroid cancer) as well as recurrent thyroid cancer.
AB - Thermal and chemical ablation are minimally invasive procedures that avoid removal of the thyroid gland and target symptomatic nodules directly. Internationally, Radiofrequency ablation (RFA) is among one of the most widely used thermal ablative techniques, and is gaining traction in North America. Surgery remains the standard of care for most thyroid cancer, and in the right clinical setting, Active Surveillance (AS) can be a reasonable option for low risk disease. Minimally invasive techniques have emerged as an alternative option for patients deemed high risk for surgery, or for those patients who wish to receive a more active treatment approach compared to AS. Herein, we review the literature on the safety and efficacy of RFA for treating benign non-functioning thyroid nodules, autonomously functioning thyroid nodules, primary small low risk thyroid cancer (namely papillary thyroid cancer) as well as recurrent thyroid cancer.
KW - autonomously functioning thyroid nodules
KW - benign thyroid nodules
KW - primary thyroid cancer
KW - radiofrequency ablation
KW - recurrent thyroid cancer
KW - thermal ablation
UR - http://www.scopus.com/inward/record.url?scp=85109705516&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109705516&partnerID=8YFLogxK
U2 - 10.3389/fendo.2021.698689
DO - 10.3389/fendo.2021.698689
M3 - Review article
C2 - 34248853
AN - SCOPUS:85109705516
SN - 1664-2392
VL - 12
JO - Frontiers in Endocrinology
JF - Frontiers in Endocrinology
M1 - 698689
ER -